Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarah Ehmann
Observed names:
Ehmann, Sarah,
S Ehmann,
S. Ehmann
Institutions:
Memorial Sloan Kettering Cancer Center,
Kliniken Essen-Mitte
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Universitätsmedizin Rostock,
Kliniken Essen-Mitte,
University of Rostock
ORCID:
0000-0003-3674-1217
Observed ORCID:
0000-0003-3674-1217
OpenAlex ID:
A5037016859
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
2022
·
Sarah Ehmann
, Dib Sassine
, et al.
·
Gynecologic Oncology
·
48
Defining the Need for Surgery in Small-Bowel Obstruction
2017
·
Florian Kuehn
, Malte Weinrich
, et al.
·
Journal of Gastrointestinal Surgery
·
28
Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients
2020
·
Sonia Prader
, Andreas du Bois
, et al.
·
Archives of Gynecology and Obstetrics
·
27
Low-grade Serous Tumors: Are We Making Progress?
2020
·
Nina Pauly
, Sarah Ehmann
, et al.
·
Current Oncology Reports
·
23
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
2023
·
William A. Zammarrelli
, Weining Ma
, et al.
·
Gynecologic Oncology
·
20
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study
2022
·
Sarah Ehmann
, Kelly Shay
, et al.
·
Gynecologic Oncology
·
19
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study
2023
·
Majdi Imterat
, Gudrun Gebers
, et al.
·
Gynecologic Oncology
·
12
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification
2022
·
William A. Zammarrelli
, Sarah H. Kim
, et al.
·
JCO Precision Oncology
·
11
Why was GOG-0213 a negative trial?
2020
·
Sarah Ehmann
, Oliver Zivanovic
, et al.
·
Journal of Gynecologic Oncology
·
10
PDF
Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer – Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
2020
·
Beyhan Ataseven
, Denise Tripon
, et al.
·
Geburtshilfe und Frauenheilkunde
·
10
PDF
Diaphragm hernia after debulking surgery in patients with ovarian cancer
2021
·
Sarah Ehmann
, Emeline M. Aviki
, et al.
·
Gynecologic Oncology Reports
·
8
PDF
Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience
2021
·
Nina Pauly
, Thaïs Baert
, et al.
·
Archives of Gynecology and Obstetrics
·
8
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
2024
·
Sarah Ehmann
, Clarissa Lam
, et al.
·
Gynecologic Oncology
·
5
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
2023
·
Tiffany Y. Sia
, Beryl L. Manning-Geist
, et al.
·
Gynecologic Oncology
·
4
Case report: Sentinel lymph node mapping of endometrial carcinoma occurring in uterine didelphys
2021
·
Dib Sassine
, Sara Moufarrij
, et al.
·
Gynecologic Oncology Reports
·
3
PDF
Minimally invasive repair of a left diaphragm hernia after debulking surgery for advanced ovarian cancer
2021
·
Sarah Ehmann
, Bernard Park
, et al.
·
Gynecologic Oncology Reports
·
3
PDF
Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center “Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)”
2026
·
Andreas du Bois
, Christina Fotopoulou
, et al.
·
International Journal of Gynecological Cancer
·
1
Cytoreductive surgery for recurrent platinum-sensitive low-grade ovarian carcinoma: a retrospective single institution experience
2025
·
Maximilian Pruss
, Mareike Bommert
, et al.
·
International Journal of Gynecological Cancer
·
1
EP159/#428 Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
2022
·
William Zammarrelli
, Kevin Espino
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Acute pericarditis after transabdominal cardiophrenic lymph node dissection and pericardotomy during ovarian cancer debulking surgery: A case report
2020
·
Dib Sassine
, Dimitrios Nasioudis
, et al.
·
Gynecologic Oncology Reports
·
1
PDF
Cytoreductive surgery and prediction of complete resection in advanced low-grade serous ovarian carcinoma: a retrospective single institution experience
2026
·
Maximilian Pruss
, Mareike Bommert
, et al.
·
International Journal of Gynecological Cancer
The surgery in recurrent ovarian cancer research consortium (suROC-CON): value of secondary cytoreduction for recurrent epithelial ovarian cancer in a multicenter, high surgical quality setting
2026
·
Irina Tsibulak
, Christina Fotopoulou
, et al.
·
International Journal of Gynecological Cancer
Identification of patients with advanced ovarian cancer (AOC) and high risk for morbidity and mortality undergoing primary therapy in a specialized ESGO certificated tertiary cancer center.
2026
·
Florian Heitz
, Andreas Du Bois
, et al.
·
International Journal of Gynecological Cancer
Evaluating the risk of diaphragmatic hernia following left diaphragm resections during cytoreductive surgery for ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study
2025
·
Ryan M. Kahn
, Sarah Anderson
, et al.
·
International Journal of Gynecological Cancer
Cytoreductive surgery for recurrent low-grade ovarian cancer
2025
·
Philipp Harter
, Malak Moubarak
, et al.
·
Gynecologic Oncology
Show more works
View as search
Works count:
50
Citation count:
243
H-index:
10
I10-index:
10
Year
Topic
Type